Major international collaboration shows clinically actionable outlook for advanced prostate cancer patients.
Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.
In-depth talks with US and EU regulators lead to accelerated approval strategy for gene therapy.
23andMe make another big hire to boost their therapeutic ambitions.
New therapeutic option now available for select treatment resistant lung cancer patients.
Clinicians, Researchers And Industry Collaborate With The 100,000 Genomes Project
New collaboration between Foundation Medicine and H3 aims to develop precision cancer therapies.
UC Berkeley & UC San Francisco launch gene-editing initiative.
Merck join the SGC with multi-million dollar contribution. Merck have announced a contribution of C$7.5 million to the Structural Genomics Consortium (SGC), joining as a member organisation. The supported project focus on per-competitive research to develop small inhibitory molecules called chemical probes to study epigenetic mechanisms of regulation. In collaboration with leading clinical institutions in […]